Mostrando 2 resultados de: 2
Ibrutinib in Refractory or Relapsing Primary Central Nervous System Lymphoma: A Systematic Review
ReviewAbstract: Primary Central Nervous System Lymphoma (PCNSL) is a rare variant of Non-Hodgkin Lymphoma (NHL) reprPalabras claves:Bruton tyrosine kinase inhibitor, BTK, Ibrutinib, Lymphoma, PCNSL, Primary central nervous system lymphomaAutores:Albert T., Bhagat R., Bhandari S., Bucheli D.H., Gajurel B.P., Joshi U., Juan Fernando Ortíz, Khurana M., Licata S., Nepal G., Ojha R., Pudasainee P., Quiñonez J., Rehrig J.H., Ruxmohan S., Shing Y.K., Stien J.Fuentes:scopusOpioid antagonist in the treatment of ischemic stroke
ArticleAbstract: Stroke is a leading cause of death and disability, and novel treatments need to be found, particularPalabras claves:Anti-opioids, clinical trials, Nalmefene, Naloxone, strokeAutores:Altamimi A., Claudio Cruz, Eissa-Garces A., Halan T., Ivan Mateo Alzamora, Juan Fernando Ortíz, Khurana M., Patel A., Patel U.K., Ruxmohan S.Fuentes:scopus